NO20032973L - Eksitatoriske aminosyrereseptorantagonister - Google Patents
Eksitatoriske aminosyrereseptorantagonisterInfo
- Publication number
- NO20032973L NO20032973L NO20032973A NO20032973A NO20032973L NO 20032973 L NO20032973 L NO 20032973L NO 20032973 A NO20032973 A NO 20032973A NO 20032973 A NO20032973 A NO 20032973A NO 20032973 L NO20032973 L NO 20032973L
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- receptor antagonists
- acid receptor
- excitatory amino
- excitatory
- Prior art date
Links
- 229940123511 Excitatory amino acid receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 | |
| PCT/US2001/044715 WO2002053561A1 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032973D0 NO20032973D0 (no) | 2003-06-27 |
| NO20032973L true NO20032973L (no) | 2003-06-27 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032973A NO20032973L (no) | 2001-01-05 | 2003-06-27 | Eksitatoriske aminosyrereseptorantagonister |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (no) |
| JP (1) | JP2004520335A (no) |
| KR (1) | KR20030066797A (no) |
| CN (1) | CN1484642A (no) |
| AR (1) | AR035679A1 (no) |
| BR (1) | BR0116672A (no) |
| CA (1) | CA2431545A1 (no) |
| CZ (1) | CZ20031856A3 (no) |
| DZ (1) | DZ3460A1 (no) |
| EA (1) | EA200300770A1 (no) |
| EC (1) | ECSP034682A (no) |
| HR (1) | HRP20030544A2 (no) |
| HU (1) | HUP0302528A2 (no) |
| IL (1) | IL156138A0 (no) |
| MX (1) | MXPA03005981A (no) |
| NO (1) | NO20032973L (no) |
| NZ (1) | NZ525821A (no) |
| PE (1) | PE20020792A1 (no) |
| PL (1) | PL361934A1 (no) |
| SK (1) | SK8242003A3 (no) |
| TW (1) | TW591023B (no) |
| WO (1) | WO2002053561A1 (no) |
| ZA (1) | ZA200304311B (no) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| CA2319652A1 (en) * | 1998-02-06 | 1999-08-12 | Michael Urquhart | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| CN1230174C (zh) * | 1999-07-06 | 2005-12-07 | 伊莱利利公司 | 治疗偏头痛的选择性iGluR5受体拮抗剂 |
-
2001
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Withdrawn
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
-
2002
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973L/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1484642A (zh) | 2004-03-24 |
| SK8242003A3 (en) | 2004-01-08 |
| EA200300770A1 (ru) | 2003-10-30 |
| BR0116672A (pt) | 2003-09-23 |
| ECSP034682A (es) | 2003-08-29 |
| NZ525821A (en) | 2004-07-30 |
| HRP20030544A2 (en) | 2004-08-31 |
| IL156138A0 (en) | 2003-12-23 |
| NO20032973D0 (no) | 2003-06-27 |
| WO2002053561A1 (en) | 2002-07-11 |
| EP1351955A1 (en) | 2003-10-15 |
| AR035679A1 (es) | 2004-06-23 |
| KR20030066797A (ko) | 2003-08-09 |
| CA2431545A1 (en) | 2002-07-11 |
| TW591023B (en) | 2004-06-11 |
| ZA200304311B (en) | 2004-09-02 |
| JP2004520335A (ja) | 2004-07-08 |
| PE20020792A1 (es) | 2002-09-06 |
| MXPA03005981A (es) | 2003-09-10 |
| CZ20031856A3 (cs) | 2003-09-17 |
| DZ3460A1 (fr) | 2002-07-11 |
| HUP0302528A2 (hu) | 2003-11-28 |
| PL361934A1 (en) | 2004-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051871D0 (no) | Opioid reseptorantagonister | |
| EP1401476A4 (en) | IGF-ANTAGONISTS PEPTIDES | |
| DK1446379T3 (da) | Arylanilin-beta2-adrenergiske receptoragonister | |
| IS7583A (is) | Kalsítóníngen-skyld peptíð viðtaka mótlyf | |
| DE60216229D1 (de) | Il-8-rezeptorantagonisten | |
| DK1163239T3 (da) | Modificerede aminosyreamider som CGRP-antagonister | |
| NO20034452L (no) | Sykdoms-assosiert protein | |
| DE60332816D1 (de) | Nk1-antagonisten | |
| BR0207810A (pt) | inibidores de deformilase de peptìdeo | |
| DE60222693D1 (de) | Nk1-antagonisten | |
| DE60226419D1 (de) | Somatostatin-antagonisten | |
| ATE397931T1 (de) | Exzitatorische aminosäure-rezeptor-antagonisten | |
| NO20032963D0 (no) | Peptidforbindelser | |
| EE200300335A (et) | Histamiiniretseptori antagonistid | |
| NO20032973D0 (no) | Eksitatoriske aminosyrereseptorantagonister | |
| DE60222015D1 (de) | Ccr-3-rezeptorantagonisten vii | |
| AU2002227020A1 (en) | Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| DE60209885D1 (de) | Crf receptor antagonisten | |
| HK1060350A (en) | Excitatory amino acid receptor antagonists | |
| AU2002228736A1 (en) | Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| NO20053512D0 (no) | IL-8-liknende proteiner | |
| NO20052608D0 (no) | Midkinlignende protein | |
| SE0100442D0 (sv) | Sammanfognings - spik | |
| SE0003996D0 (sv) | Receptorantagonister | |
| ATA522002A (de) | Vmp-bindungsprotein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |